Related Experiment Video
Updated: May 4, 2026

The Rabbit Blood-shunt Model for the Study of Acute and Late Sequelae of Subarachnoid Hemorrhage: Technical Aspects
Published on: October 2, 2014
Shunting in acute cerebral venous thrombosis: a systematic review
S Lobo1, J M Ferro, F Barinagarrementeria
1Department of Neurosciences (Neurology), Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal.
Insights
Cerebrospinal fluid shunting in acute cerebral venous thrombosis (CVT) shows limited efficacy, with only half of patients regaining independence and a quarter dying. Shunting may benefit select patients with sustained intracranial hypertension but no parenchymal lesions.
Area of Science:
- Neurology
- Neurosurgery
- Vascular Neurology
Background:
- Acute cerebral venous thrombosis (CVT) poses a risk of intracranial hypertension and fatal brain herniation.
- The effectiveness of cerebrospinal fluid (CSF) shunting in managing these complications in CVT is not well-established.
Purpose of the Study:
- To evaluate the efficacy of CSF shunting in treating acute CVT patients.
- To determine if shunting reduces intracranial hypertension and prevents brain herniation in acute CVT.
Main Methods:
- A systematic review and analysis of patients from the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) treated with shunting.
- Outcome assessment at 6 months and final follow-up using the modified Rankin Scale (mRS).
Main Results:
- Fifteen patients received shunting (6 external ventricular drain, 8 ventriculoperitoneal).
- 53.3% achieved independence (mRS 0-2), 13.3% had severe disability (mRS 4-6), and 26.7% died.
- Patients with intracranial hypertension and no parenchymal lesions treated later than 48 hours with a ventriculoperitoneal shunt showed favorable outcomes.
Conclusions:
- Shunting in acute CVT has a high mortality rate (26.7%) and limited success in achieving independence (53.3%).
- Current evidence suggests shunting may not be effective in preventing herniation in acute CVT.
- Shunting might offer benefits for specific patient subgroups with sustained intracranial hypertension and no parenchymal lesions.
Background And Purpose:
The efficacy of cerebrospinal fluid shunting to reduce intracranial hypertension and prevent fatal brain herniation in acute cerebral venous thrombosis (CVT) is unknown.
Method:
From the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) and a systematic literature review, we retrieved acute CVT patients treated only with shunting (external ventricular drain, ventriculoperitoneal or ventriculojugular shunt). Outcome was classified at 6 months and final follow-up by the modified Rankin Scale (mRS).
Results:
15 patients were collected (9 from the ISCVT and 6 from the review) who were treated with a shunt (external ventricular drain in 6 patients, a ventriculoperitoneal shunt in 8 patients or an unspecified type of shunt in another one). Eight patients (53.3%) regained independence (mRS 0-2), while 2 patients (13.3%) were left with a severe handicap (mRS 4-6) and 4 (26.7%) died despite treatment. Five patients with parenchymal lesions were shunted within 48 h from admission deterioration, 4 with an external ventricular drain: 2 (40%) recovered to independence, 2 (40%) had a severe handicap and 1 (20%) died. In contrast, all 3 patients with intracranial hypertension and no parenchymal lesions receiving a ventriculoperitoneal shunt later than 48 h regained independence.
Conclusion And Implications:
A quarter of acute CVT patients treated with a shunt died, and only half regained independence. With the limitation of the small number of subjects, this review suggests that shunting does not appear to be effective in preventing death from brain herniation in acute CVT. We cannot exclude that shunting may benefit patients with sustained intracranial hypertension and no parenchymal lesions.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis I: Introduction
Cerebral Edema ll: Pathophysiology

